Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gonal-f 1,050unit inj vials
0605010I0BBAFAF
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 150unit inj ampoules
0605010I0BBABAB
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 300units/0.48ml inj pre-filled pens
0605010I0BBANAU
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 300units/0.5ml inj pre-filled syringes
0605010I0BBAHAH
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 37.5unit inj ampoules
0605010I0BBACAC
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 450unit inj vials
0605010I0BBAGAG
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 450units/0.72ml inj pre-filled pens
0605010I0BBAPAV
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 450units/0.75ml inj pre-filled syringes
0605010I0BBAIAI
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 75unit inj ampoules
0605010I0BBAAAA
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 75unit inj vials
0605010I0BBAEAE
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 900units/1.5ml inj pre-filled syringes
0605010I0BBAJAJ
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonasi HP 2,000unit inj vials
0605010D0BFAAAH
|
Gonasi HP | Chorionic gonadotrophin | Endocrine System | No data available |
|
Guar gum 5g granules sachets sugar free
0601023I0AAADAD
|
Guar gum | Guar gum | Endocrine System | No data available |
|
Guarem 5g granules sachets
0601023I0BCAAAD
|
Guarem | Guar gum | Endocrine System | No data available |
|
Gynokadin 0.06% gel
0604011G0BXAAAU
|
Gynokadin | Estradiol | Endocrine System | No data available |
|
Harmogen 1.5mg tablets
0604011R0BBAAAA
|
Harmogen | Estropipate | Endocrine System | No data available |
|
HRF 100microgram inj vials
0605010P0BCAAAA
|
HRF | Gonadorelin | Endocrine System | No data available |
|
HumaJect M3 Pen 100units/ml suspension for injection
0601012D0BBAMBZ
|
Insulin Humulin | Biphasic isophane insulin | Endocrine System | No data available |
|
HumaJect S Pen 100units/ml solution for injection
0601011N0BHACAM
|
Insulin Humulin S (Soluble) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Humalog 100units/ml solution for injection 1.5ml cartridges
0601011L0BBAAAA
|
Insulin Humalog | Insulin Lispro | Endocrine System | No data available |
|
Humalog Mix25 Pen 100units/ml inj 3ml pre-filled pens
0601012F0BBAAAA
|
Insulin Humalog Mix | Biphasic insulin lispro | Endocrine System | No data available |
|
Human Actrapid Penfill 100units/ml inj 1.5ml cartridges
0601011N0BFAJAD
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Human Insulatard Penfill 100units/ml inj 1.5ml cartridges
0601012S0BDAKAM
|
Insulin isophane (Novo-Nordisk) | Isophane insulin | Endocrine System | No data available |
|
Human Mixtard 10 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCAMBJ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Human Mixtard 20 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCANBE
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.